Nanobiotechnology and Nanomedicine Companies
Showing results 21 - 40 of 45 for suppliers of Biomaterials:
The company's lead product in development is Amorphous Nano-Hydroxyapaite Powder. Nano-structured hydroxyapatite has several advantages over hydroxyapatite of larger particle size in its use in bone tissue engineering due to its higher surface area and consequently higher reactivity, which offers better cellular response. In addition, nano-sized hydroxyapatite is useful as an effective surface modification agent for binding numerous biological molecules.
Design, synthesis and manufacture of biocompatible nanoparticles called nanocells.
Mirexus Inc. is a natural biomaterials company that is commercializing a novel nanotechnology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to biomedical applications in animal and human health. This technology was originally developed at the University of Guelph in the laboratories of Professor John Dutcher.
Develops complete surface solutions for medical implants based on bionanotechnology.
Nano Bridging Molecules is devoted to researching, developing, manufacturing, and marketing its patented SurfLink® range of advanced medical implant surface modifications designed to render medical implants biocompatible with the human body.
The company has developed an innovative cancer treatment using magnetosomes (magnetic nanoparticles synthesized by magnetotactic bacteria), which are administered to tumors and heated by applying an alternating magnetic field. This method of treatment is called magnetic hyperthermia. The heat released by the magnetosomes induces antitumor activity.
A biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines, based on its nanotechnology platform.
NanoBiotech is a broad-based life science company that discovers, develops, manufactures and markets a range of nanobiotics and medical diagnostics designed to improve people's health and longevity.
Nanofiber Solutions designs and manufactures novel 3D nanofiber scaffolds. The company's 3D cell culture products NanoAligned and NanoECM were developed for life science research. Nanofiber Solutions novel platform technology provides researchers with more biologically realistic 3-dimensional in vivo cell culture environment.
Nanoimmunotech is a Spanish company in the Nanobiotechnology sector, founded in August 2009, recognized as EIBT (Technologically Innovative Company) and Spin-off of form the Universities of Vigo and Zaragoza. It is the first European company dedicated to the biological and physico-chemical characterization and functionalization of nanoparticles (conjugation with different molecules such as nucleid acids, enzimes, antibodies, carbohydrates, peptides) and production of specific monoclonal antibodies (on demand).
Design, synthesis, and analysis of small molecule organic compounds for the pharmaceutical industry.
Novavax is focused on creating novel, highly potent recombinant vaccines produced via cell culture. The company has developed three proprietary technology platforms: Virus-Like Particles, NovasomeŽ paucilamellar vesicles and Micellar Nanoparticles.
Develops, manufactures and commercializes medical products based on nanocrystalline silver technology.
Oasmia Pharmaceutical AB develops next generation cancer drugs based on nanotechnology for human and veterinary use.
OmegaGenesis, Inc. is a biotechnology company that discovers and produces nano-scale materials that work on the cellular and sub-cellular level to promote or inhibit angiogenesis, the growth of new blood vessels.
Parabon NanoLabs designs and develops a new class of therapeutics and other products made possible by proprietary technology for precisely directing the self-assembly of designer macromolecules that are functionalized with molecular subcomponents (e.g., enzymes, metals or pharmaceuticals).
Particle Sciences is an integrated provider of both standard and nanotechnology approaches to drug development and delivery. The company originally pioneered use of encapsulated ingredients and nanoparticles for sunscreens and personal care. In 1999 the company licensed a portion of its nanotechnology portfolio to BASF and focused its efforts on providing services to Life Sciences companies. Now, through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution designed to minimize the time and risk between discovery and the clinic.
The company manufactures custom nanoparticle dispersions and also provides nanoparticle coating for metallic products, for instance for medical instruments.
The company developed the Artiste™ Nano Composite System for dental restoration.
The company develops, produces and markets nanotechnologies for the life sciences. They produce a variety of nano-structured surfaces for use in research and are also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions.